| 國家衛生研究院 |
2014-02 |
CDCA5 overexpression as a poor prognostic factor in patients with urothelial carcinomas of upper urinary tract and urinary bladder
|
Chang, IW;Hung, CH;Li, CF |
| 國家衛生研究院 |
2015-04 |
CDCA5 overexpression is an indicator of poor prognosis in patients with urothelial carcinomas of the upper urinary tract and urinary bladder
|
Chang, IW;Lin, VC;He, HL;Hsu, CT;Li, CC;Wu, WJ;Huang, CN;Wu, TF;Li, CF |
| 義守大學 |
2015-04 |
CDCA5 overexpression is an indicator of poor prognosis in patients with urothelial carcinomas of the upper urinary tract and urinary bladder
|
I-Wei Chang;Victor Chia-Hsiang Lin;Hong-Lin He;Chao-Tien Hsu;Ching-Chia Li;Wen-Jeng Wu;Chun-Nung Huang;Ting-Feng Wu;Chien-Feng Li |
| 國立高雄應用科技大學 |
2004 |
CdCl2對利用網印法所製成之CdS及CdTe層其應用於太陽電池的光電特性改善
|
蔡泰成; Cai, Tai-Cheng |
| 國立成功大學 |
2023-03-2 |
CDCP1 (CUB domain containing protein 1) is a potential urine-based biomarker in the diagnosis of low-grade urothelial carcinoma
|
Liu;Chien-Liang;Tsai;Hung-Wen;Peng;Shu-Ling;Chang;Ching-Ping;Chang;Yu-Hao;Huang;Huei-Sheng |
| 國立成功大學 |
2022-03-22 |
CDCP1 促進尿路上皮癌中巨噬細胞的聚集及分化作用
|
譚凱霖; Tam, Hoi-Lam |
| 國立成功大學 |
2025-04-23 |
CDCP1在 TGF-β1相關癌化作用的角色
|
鄭亦茹; Zheng, Yi-Ru |
| 國立成功大學 |
2020-08-28 |
CDCP1在具有Gemcitabine抗藥性的尿路上皮癌中所扮演的角色
|
Chen, Hui-Tzu; 陳慧慈 |
| 中國醫藥大學 |
2019-07-10 |
CDCP1抑制劑用於癌症治療之中草藥開發
|
張勳瑜;Xun-Yu Zhang |
| 國立成功大學 |
2023-07-31 |
CDCP1藉由the c-Src/PKC-delta路徑促進尿路上皮癌細胞的幹細胞特性
|
張宜雯; Chang, Yi-Wen |
| 元培科技大學 |
2017-11-13 |
CDC藥瓶檢測法檢測南部地區登革熱病媒蚊的抗藥性
|
廖翊豪;林鶯熹 |
| 國立臺灣大學 |
2005 |
cdeNDI:一個有效率的頻繁項目集探勘演算法
|
黃健銘; Huang, Chien-Ming |
| 臺大學術典藏 |
2019-12-26T07:59:33Z |
CDF run IIb silicon detector: Electrical performance and deadtime-less operation
|
Akimoto, T.; Akimoto, T.; RONG-SHYANG LU |
| 臺大學術典藏 |
2019-12-26T07:59:31Z |
CDF run IIb silicon detector: The innermost layer
|
Merkel, P.; Merkel, P.; RONG-SHYANG LU |
| 臺大學術典藏 |
2019-12-26T07:59:31Z |
CDF run IIb silicon vertex detector DAQ upgrade
|
Behari, S.; Behari, S.; RONG-SHYANG LU |
| 臺大學術典藏 |
2019-12-26T07:59:32Z |
CDF run IIb silicon: Design and testing
|
Lu, R.-S.; Lu, R.-S.; RONG-SHYANG LU |
| 國立交通大學 |
2014-12-12T02:05:35Z |
CDFA--一個有管制的資料流處理機架構之設計
|
溫俊宏; WEN, JUN-HONG; 鍾崇斌; ZHONG, CHONG-BIN |
| 國家衛生研究院 |
2023-11-28 |
CDGSH iron sulfur domain 2 activators and use thereof
|
Tsai, TF;Lee, JC;Yeh, TK |
| 國家衛生研究院 |
2023-09-11 |
CDGSH鐵硫結構域２活化劑及其用途
|
蔡亭芬;李靜琪;葉燈光 |
| 中國醫藥大學 |
2014-03 |
CDH1 polymorphisms and haplotypes in sporadic diffuse and intestinal gastric cancer: a case–control study based on direct sequencing analysis
|
(Chi-Ming Chu);(Cheng-Jueng Chen);(De-Chuan Chan);(Hurng-Sheng Wu);(Yao-Chi Liu)*;(Chen-Yang Shen);(Tzu-Ming Chang);(Jyh-cherng Yu);韓鴻志(Horng-Jyh Harn);(Cheng-Ping Yu);(Ming-Hsin Yang) |
| 臺大學術典藏 |
2019-02-20T06:37:22Z |
CDH1, DLEC1 and SFRP5 methylation panel as a prognostic marker for advanced epithelial ovarian cancer
|
Lin, Hsiu-Ping;Chang, Ming-Cheng;Fu, Chi-Feng;Wen-Fang Cheng;Chi-An Chen;Ying-Cheng Chiang;Tzu-Pin Lu;Lin, Han-Wei; Lin, Han-Wei; Fu, Chi-Feng; Chang, Ming-Cheng; TZU-PIN LU; Lin, Hsiu-Ping; YING-CHENG CHIANG; CHI-AN CHEN; WEN-FANG CHENG |
| 臺大學術典藏 |
2020-01-22T07:50:23Z |
CDH1, DLEC1 and SFRP5 methylation panel as a prognostic marker for advanced epithelial ovarian cancer
|
Lin H.-W.;Fu C.-F.;Chang M.-C.;Lu T.-P.;Lin H.-P.;Chiang Y.-C.;Chi-An Chen;Cheng W.-F.; Lin H.-W.; Fu C.-F.; Chang M.-C.; Lu T.-P.; Lin H.-P.; Chiang Y.-C.; CHI-AN CHEN; Cheng W.-F. |
| 臺大學術典藏 |
2020-02-06T05:21:48Z |
CDH1, DLEC1 and SFRP5 methylation panel as a prognostic marker for advanced epithelial ovarian cancer
|
WEN-FANG CHENG;Chen C.-A.;Chiang Y.-C.;Lin H.-P.;Lu T.-P.;Chang M.-C.;Fu C.-F.;Lin H.-W.; Lin H.-W.; Fu C.-F.; Chang M.-C.; Lu T.-P.; Lin H.-P.; Chiang Y.-C.; Chen C.-A.; WEN-FANG CHENG; Lin H.-W.; Fu C.-F.; Chang M.-C.; Lu T.-P.; Lin H.-P.; Chiang Y.-C.; Chen C.-A.; WEN-FANG CHENG |
| 臺大學術典藏 |
2020-02-14T08:50:30Z |
CDH1, DLEC1 and SFRP5 methylation panel as a prognostic marker for advanced epithelial ovarian cancer
|
Cheng W.-F.; Chen C.-A; YING-CHENG CHIANG; Lin H.-P; Lu T.-P; Chang M.-C; Fu C.-F; Lin H.-W |
| 臺大學術典藏 |
2020-11-17T02:45:23Z |
CDH1, DLEC1 and SFRP5 methylation panel as a prognostic marker for advanced epithelial ovarian cancer
|
Lin H.-W.;Fu C.-F.;Chang M.-C.;Tzu-Pin Lu;Lin H.-P.;Chiang Y.-C.;Chen C.-A.;Cheng W.-F.; Lin H.-W.; Fu C.-F.; Chang M.-C.; TZU-PIN LU; Lin H.-P.; Chiang Y.-C.; Chen C.-A.; Cheng W.-F. |
